350 related articles for article (PubMed ID: 17161070)
1. Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction.
Ohlmann P; Jaquemin L; Morel O; El Behlgiti R; Faure A; Michotey MO; Beranger N; Roul G; Schneider F; Bareiss P; Monassier JP
Am Heart J; 2006 Dec; 152(6):1161-7. PubMed ID: 17161070
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
4. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
[TBL] [Abstract][Full Text] [Related]
5. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
Nienhuis MB; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
Coron Artery Dis; 2009 Jan; 20(1):9-14. PubMed ID: 19050596
[TBL] [Abstract][Full Text] [Related]
6. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.
Hallén J; Buser P; Schwitter J; Petzelbauer P; Geudelin B; Fagerland MW; Jaffe AS; Atar D
Am J Cardiol; 2009 Dec; 104(11):1472-7. PubMed ID: 19932777
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
[TBL] [Abstract][Full Text] [Related]
8. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.
Selvanayagam JB; Porto I; Channon K; Petersen SE; Francis JM; Neubauer S; Banning AP
Circulation; 2005 Mar; 111(8):1027-32. PubMed ID: 15723982
[TBL] [Abstract][Full Text] [Related]
9. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
[TBL] [Abstract][Full Text] [Related]
10. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.
Januzzi JL; Newby LK; Murphy SA; Pieper K; Antman EM; Morrow DA; Sabatine MS; Ohman EM; Cannon CP; Braunwald E
Am Heart J; 2006 Feb; 151(2):360-6. PubMed ID: 16442899
[TBL] [Abstract][Full Text] [Related]
11. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
[TBL] [Abstract][Full Text] [Related]
12. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
[TBL] [Abstract][Full Text] [Related]
13. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.
Smit JJ; Ottervanger JP; Slingerland RJ; Kolkman JJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ; Zijlstra F; van 't Hof AW;
Am J Cardiol; 2008 Feb; 101(4):446-51. PubMed ID: 18312755
[TBL] [Abstract][Full Text] [Related]
14. Cardiac troponin I level correlates with chronic-phase left ventricular function after successful direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
Hara S; Horinaka S; Tsuchiya N; Yabe A; Asakawa H; Yagi H
J Cardiol; 2000 Nov; 36(5):303-10. PubMed ID: 11107552
[TBL] [Abstract][Full Text] [Related]
15. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
[TBL] [Abstract][Full Text] [Related]
17. Low adiponectin blood concentration predicts left ventricular remodeling after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Piestrzeniewicz K; Luczak K; Maciejewski M; Drozdz J
Cardiol J; 2010; 17(1):49-56. PubMed ID: 20104457
[TBL] [Abstract][Full Text] [Related]
18. Role of serum troponin-I in identifying left ventricular ejection fraction of Shaikh AH; Hanif B; Lakhani MS; Malik F; Qazi HA; Mujtaba I
J Coll Physicians Surg Pak; 2009 Sep; 19(9):544-7. PubMed ID: 19728937
[TBL] [Abstract][Full Text] [Related]
19. Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention.
Boden H; Ahmed TA; Velders MA; van der Hoeven BL; Hoogslag GE; Bootsma M; le Cessie S; Cobbaert CM; Delgado V; van der Laarse A; Schalij MJ
Am J Cardiol; 2013 May; 111(10):1387-93. PubMed ID: 23465094
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
